Annual EBIT
-$18.80 M
+$4.09 M+17.87%
December 31, 2023
Summary
- As of February 8, 2025, APYX annual earnings before interest & taxes is -$18.80 million, with the most recent change of +$4.09 million (+17.87%) on December 31, 2023.
- During the last 3 years, APYX annual EBIT has risen by +$559.00 thousand (+2.89%).
- APYX annual EBIT is now -763.12% below its all-time high of $2.84 million, reached on December 31, 2008.
Performance
APYX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$3.23 M
+$1.88 M+36.72%
September 30, 2024
Summary
- As of February 8, 2025, APYX quarterly earnings before interest & taxes is -$3.23 million, with the most recent change of +$1.88 million (+36.72%) on September 30, 2024.
- Over the past year, APYX quarterly EBIT has increased by +$2.91 million (+47.35%).
- APYX quarterly EBIT is now -291.56% below its all-time high of $1.69 million, reached on December 31, 2008.
Performance
APYX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$22.90 M
+$1.18 M+4.88%
September 30, 2024
Summary
- As of February 8, 2025, APYX TTM earnings before interest & taxes is -$22.90 million, with the most recent change of +$1.18 million (+4.88%) on September 30, 2024.
- Over the past year, APYX TTM EBIT has dropped by -$3.52 million (-18.18%).
- APYX TTM EBIT is now -834.36% below its all-time high of $3.12 million, reached on June 30, 2009.
Performance
APYX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
APYX EBIT Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +17.9% | +47.4% | -18.2% |
3 y3 years | +2.9% | +22.3% | -54.2% |
5 y5 years | -28.9% | +23.0% | -15.5% |
APYX EBIT Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -27.0% | +17.9% | -688.5% | +61.6% | -54.6% | +4.9% |
5 y | 5-year | -27.0% | +17.9% | -688.5% | +61.6% | -54.6% | +4.9% |
alltime | all time | -763.1% | +17.9% | -291.6% | +66.1% | -834.4% | +4.9% |
Apyx Medical EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$3.23 M(-36.7%) | -$22.90 M(-4.9%) |
Jun 2024 | - | -$5.11 M(-16.8%) | -$24.08 M(+24.2%) |
Mar 2024 | - | -$6.14 M(-27.1%) | -$19.38 M(+3.1%) |
Dec 2023 | -$18.80 M(-17.9%) | -$8.42 M(+91.0%) | -$18.80 M(+15.4%) |
Sep 2023 | - | -$4.41 M(+975.1%) | -$16.29 M(-7.6%) |
Jun 2023 | - | -$410.00 K(-92.6%) | -$17.63 M(-21.9%) |
Mar 2023 | - | -$5.57 M(-5.9%) | -$22.57 M(-1.4%) |
Dec 2022 | -$22.90 M(+54.6%) | -$5.91 M(+2.9%) | -$22.90 M(+21.4%) |
Sep 2022 | - | -$5.74 M(+7.3%) | -$18.86 M(+9.2%) |
Jun 2022 | - | -$5.35 M(-9.2%) | -$17.27 M(+8.9%) |
Mar 2022 | - | -$5.89 M(+214.1%) | -$15.87 M(+7.1%) |
Dec 2021 | -$14.81 M(-23.5%) | -$1.88 M(-54.9%) | -$14.81 M(-0.3%) |
Sep 2021 | - | -$4.16 M(+5.5%) | -$14.85 M(-1.8%) |
Jun 2021 | - | -$3.94 M(-18.5%) | -$15.12 M(-12.9%) |
Mar 2021 | - | -$4.83 M(+152.5%) | -$17.35 M(-10.4%) |
Dec 2020 | -$19.36 M(-2.3%) | -$1.92 M(-56.7%) | -$19.36 M(-16.7%) |
Sep 2020 | - | -$4.42 M(-28.3%) | -$23.26 M(+1.0%) |
Jun 2020 | - | -$6.17 M(-9.9%) | -$23.03 M(+9.3%) |
Mar 2020 | - | -$6.85 M(+17.9%) | -$21.08 M(+6.3%) |
Dec 2019 | -$19.83 M(+35.9%) | -$5.81 M(+38.3%) | -$19.83 M(-1.7%) |
Sep 2019 | - | -$4.20 M(-0.5%) | -$20.17 M(+7.5%) |
Jun 2019 | - | -$4.22 M(-24.7%) | -$18.75 M(+7.6%) |
Mar 2019 | - | -$5.60 M(-8.9%) | -$17.42 M(+19.6%) |
Dec 2018 | -$14.59 M(+6.5%) | -$6.15 M(+120.4%) | -$14.57 M(+26.9%) |
Sep 2018 | - | -$2.79 M(-3.4%) | -$11.47 M(-0.4%) |
Jun 2018 | - | -$2.89 M(+5.1%) | -$11.52 M(+16.4%) |
Mar 2018 | - | -$2.75 M(-10.1%) | -$9.90 M(+12.5%) |
Dec 2017 | -$13.70 M(+21.0%) | -$3.05 M(+7.8%) | -$8.80 M(-36.1%) |
Sep 2017 | - | -$2.83 M(+123.4%) | -$13.78 M(+16.0%) |
Jun 2017 | - | -$1.27 M(-23.1%) | -$11.87 M(+7.2%) |
Mar 2017 | - | -$1.65 M(-79.5%) | -$11.07 M(-2.3%) |
Dec 2016 | -$11.33 M(+118.4%) | -$8.03 M(+764.8%) | -$11.33 M(+143.4%) |
Sep 2016 | - | -$928.00 K(+97.9%) | -$4.66 M(-11.7%) |
Jun 2016 | - | -$469.00 K(-75.4%) | -$5.27 M(-15.8%) |
Mar 2016 | - | -$1.91 M(+41.0%) | -$6.26 M(+20.8%) |
Dec 2015 | -$5.19 M(-60.5%) | -$1.35 M(-12.6%) | -$5.18 M(+67.7%) |
Sep 2015 | - | -$1.55 M(+6.1%) | -$3.09 M(-44.7%) |
Jun 2015 | - | -$1.46 M(+76.1%) | -$5.59 M(+26.4%) |
Mar 2015 | - | -$828.00 K(-211.6%) | -$4.42 M(-66.3%) |
Dec 2014 | -$13.13 M(+129.8%) | $742.00 K(-118.4%) | -$13.13 M(-21.9%) |
Sep 2014 | - | -$4.04 M(+1284.6%) | -$16.82 M(+27.1%) |
Jun 2014 | - | -$292.00 K(-96.9%) | -$13.24 M(-9.1%) |
Mar 2014 | - | -$9.54 M(+224.3%) | -$14.56 M(+154.7%) |
Dec 2013 | -$5.71 M(-636.1%) | -$2.94 M(+536.8%) | -$5.72 M(+127.0%) |
Sep 2013 | - | -$462.00 K(-71.4%) | -$2.52 M(+31.9%) |
Jun 2013 | - | -$1.61 M(+130.8%) | -$1.91 M(>+9900.0%) |
Mar 2013 | - | -$699.00 K(-373.0%) | -$12.00 K(-101.1%) |
Dec 2012 | $1.07 M(+296.3%) | $256.00 K(+74.1%) | $1.07 M(-319.8%) |
Sep 2012 | - | $147.00 K(-48.2%) | -$485.00 K(+7.5%) |
Jun 2012 | - | $284.00 K(-25.1%) | -$451.00 K(+470.9%) |
Mar 2012 | - | $379.00 K(-129.3%) | -$79.00 K(-129.5%) |
Dec 2011 | $269.00 K | -$1.29 M(-815.5%) | $268.00 K(-213.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2011 | - | $181.00 K(-72.4%) | -$237.00 K(-32.5%) |
Jun 2011 | - | $656.00 K(-9.6%) | -$351.00 K(-80.5%) |
Mar 2011 | - | $726.00 K(-140.3%) | -$1.80 M(-36.0%) |
Dec 2010 | -$2.24 M(-413.1%) | -$1.80 M(-2786.6%) | -$2.81 M(+181.5%) |
Sep 2010 | - | $67.00 K(-108.5%) | -$997.90 K(-15.1%) |
Jun 2010 | - | -$791.00 K(+177.5%) | -$1.18 M(+982.3%) |
Mar 2010 | - | -$285.00 K(-2667.6%) | -$108.60 K(-115.1%) |
Dec 2009 | $715.00 K(-74.8%) | $11.10 K(-110.0%) | $719.10 K(-70.0%) |
Sep 2009 | - | -$110.50 K(-140.1%) | $2.40 M(-23.2%) |
Jun 2009 | - | $275.80 K(-49.2%) | $3.12 M(+1.0%) |
Mar 2009 | - | $542.70 K(-67.8%) | $3.09 M(+9.0%) |
Dec 2008 | $2.84 M(+34.6%) | $1.69 M(+175.5%) | $2.83 M(+81.0%) |
Sep 2008 | - | $612.70 K(+149.7%) | $1.57 M(-5.9%) |
Jun 2008 | - | $245.40 K(-15.1%) | $1.66 M(-16.8%) |
Mar 2008 | - | $288.90 K(-31.1%) | $2.00 M(-4.8%) |
Dec 2007 | $2.11 M(-19.7%) | $419.20 K(-41.0%) | $2.10 M(+1.1%) |
Sep 2007 | - | $710.80 K(+22.4%) | $2.08 M(-5.5%) |
Jun 2007 | - | $580.70 K(+48.7%) | $2.20 M(-5.6%) |
Mar 2007 | - | $390.60 K(-1.7%) | $2.33 M(-11.5%) |
Dec 2006 | $2.62 M(+549.5%) | $397.20 K(-52.2%) | $2.63 M(+4.4%) |
Sep 2006 | - | $830.70 K(+16.8%) | $2.52 M(+36.0%) |
Jun 2006 | - | $711.50 K(+2.4%) | $1.86 M(+82.2%) |
Mar 2006 | - | $694.60 K(+142.9%) | $1.02 M(+150.7%) |
Dec 2005 | $404.00 K(-68.2%) | $286.00 K(+74.9%) | $406.40 K(+93.0%) |
Sep 2005 | - | $163.50 K(-230.4%) | $210.60 K(-63.3%) |
Jun 2005 | - | -$125.40 K(-252.4%) | $573.80 K(-48.2%) |
Mar 2005 | - | $82.30 K(-8.8%) | $1.11 M(-12.7%) |
Dec 2004 | $1.27 M(+91.2%) | $90.20 K(-82.9%) | $1.27 M(+45.8%) |
Sep 2004 | - | $526.70 K(+29.1%) | $870.30 K(+12.8%) |
Jun 2004 | - | $408.00 K(+67.4%) | $771.80 K(-8.0%) |
Mar 2004 | - | $243.70 K(-179.1%) | $839.20 K(+26.5%) |
Dec 2003 | $663.50 K(-240.0%) | -$308.10 K(-172.0%) | $663.50 K(+4.0%) |
Sep 2003 | - | $428.20 K(-9.9%) | $637.90 K(+306.0%) |
Jun 2003 | - | $475.40 K(+599.1%) | $157.10 K(-143.3%) |
Mar 2003 | - | $68.00 K(-120.4%) | -$362.90 K(-23.4%) |
Dec 2002 | -$473.90 K(-175.0%) | -$333.70 K(+534.4%) | -$473.90 K(+771.1%) |
Sep 2002 | - | -$52.60 K(+17.9%) | -$54.40 K(-116.3%) |
Jun 2002 | - | -$44.60 K(+3.7%) | $333.20 K(-32.7%) |
Mar 2002 | - | -$43.00 K(-150.1%) | $495.40 K(-21.6%) |
Dec 2001 | $632.10 K(+19.3%) | $85.80 K(-74.4%) | $631.50 K(+5.4%) |
Sep 2001 | - | $335.00 K(+184.9%) | $599.40 K(+41.1%) |
Jun 2001 | - | $117.60 K(+26.3%) | $424.70 K(-25.0%) |
Mar 2001 | - | $93.10 K(+73.4%) | $566.00 K(+6.8%) |
Dec 2000 | $529.90 K(-15.4%) | $53.70 K(-66.5%) | $529.90 K(+11.3%) |
Sep 2000 | - | $160.30 K(-38.1%) | $476.20 K(+50.7%) |
Jun 2000 | - | $258.90 K(+354.2%) | $315.90 K(+454.2%) |
Mar 2000 | - | $57.00 K | $57.00 K |
Dec 1999 | $626.00 K(-168.0%) | - | - |
Dec 1998 | -$920.20 K(-371.0%) | - | - |
Dec 1997 | $339.60 K(-29.3%) | - | - |
Dec 1996 | $480.40 K(-318.9%) | - | - |
Dec 1995 | -$219.50 K | - | - |
FAQ
- What is Apyx Medical annual earnings before interest & taxes?
- What is the all time high annual EBIT for Apyx Medical?
- What is Apyx Medical annual EBIT year-on-year change?
- What is Apyx Medical quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Apyx Medical?
- What is Apyx Medical quarterly EBIT year-on-year change?
- What is Apyx Medical TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Apyx Medical?
- What is Apyx Medical TTM EBIT year-on-year change?
What is Apyx Medical annual earnings before interest & taxes?
The current annual EBIT of APYX is -$18.80 M
What is the all time high annual EBIT for Apyx Medical?
Apyx Medical all-time high annual earnings before interest & taxes is $2.84 M
What is Apyx Medical annual EBIT year-on-year change?
Over the past year, APYX annual earnings before interest & taxes has changed by +$4.09 M (+17.87%)
What is Apyx Medical quarterly earnings before interest & taxes?
The current quarterly EBIT of APYX is -$3.23 M
What is the all time high quarterly EBIT for Apyx Medical?
Apyx Medical all-time high quarterly earnings before interest & taxes is $1.69 M
What is Apyx Medical quarterly EBIT year-on-year change?
Over the past year, APYX quarterly earnings before interest & taxes has changed by +$2.91 M (+47.35%)
What is Apyx Medical TTM earnings before interest & taxes?
The current TTM EBIT of APYX is -$22.90 M
What is the all time high TTM EBIT for Apyx Medical?
Apyx Medical all-time high TTM earnings before interest & taxes is $3.12 M
What is Apyx Medical TTM EBIT year-on-year change?
Over the past year, APYX TTM earnings before interest & taxes has changed by -$3.52 M (-18.18%)